Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.

Tempus AI, Inc.

Intema Insaat ve Tesisat Malzemeleri Yatirim ve Pazarlama A.S. ( ($TR:INTEM) ) just unveiled an announcement. Intema Insaat ve Tesisat Malzemeleri ...

Intema Appoints New Investor Relations Manager and Governance Committee Member

Intema Insaat ve Tesisat Malzemeleri Yatirim ve Pazarlama A.S. ( ($TR:INTEM) ) has provided an update. Intema Insaat ve Tesisat Malzemeleri Yatirim...

Intema Strengthens Investor Relations and Governance Oversight

The latest update is out from Intema Insaat ve Tesisat Malzemeleri Yatirim ve Pazarlama A.S. ( ($TR:INTEM) ). Intema has updated its corporate gove...

Intema Details Board Committee Structure in Governance Update

Tongcheng Travel Holdings Limited ( ($HK:0780) ) has provided an update. Tongcheng Travel reported unaudited results for the quarter ended June 30,...

Tongcheng Travel Lifts Q2 Revenue and Profit Despite Decline in Paying Users

Tongcheng Travel Holdings Limited ( ($HK:0780) ) has provided an update. Dida Inc., together with offeror eLong, Inc. and offeror parent Tongcheng ...

Dida Inc. Share Offer Closes With 88.74% Acceptance and Public Float Shortfall

Tempus AI (NASDAQ:TEM) stock is soaring about 22% on Wednesday, with Moderna’s huge melanoma win giving investors a new reason to reconsider the va...

‘Prepare for What’s Coming,’ Says Investor About Tempus AI Stock

Tempus AI ($TEM) surged nearly 24% on Wednesday after a major Phase 3 cancer vaccine update from Merck ($MRK) and Moderna ($MRNA). The news instant...

Tempus AI Stock (TEM) Is Surging 24% on Wednesday – Here’s Why

An update from Tembo Global Industries Ltd. ( ($IN:TEMBO) ) is now available. Tembo Global Industries Ltd. has notified the National Stock Exchange...

Tembo Global Publishes Q1 FY27 Unaudited Results in Newspapers

Tembo Global Industries Ltd. ( ($IN:TEMBO) ) has shared an update. Tembo Global Industries Ltd. has notified the National Stock Exchange of India t...

Tembo Global Industries Schedules Virtual EGM, Publishes Regulatory Notices

Intema Insaat ve Tesisat Malzemeleri Yatirim ve Pazarlama A.S. ( ($TR:INTEM) ) has shared an announcement. Trading in INTEM.E shares has been shift...

INTEM.E Moves to Single-Price Trading Under Circuit Breaker Regime

Bank of America Securities analyst maintained a Buy rating on Tongcheng Travel Holdings Limited on August 6 and set a price target of HK$19.00. The...

Bank of America Securities Remains a Buy on Tongcheng Travel Holdings Limited (0780)

In a report released today, David Westenberg from Piper Sandler reiterated a Hold rating on Tempus AI, Inc. Class A, with a price target of $56.00....

Piper Sandler Keeps Their Hold Rating on Tempus AI, Inc. Class A (TEM)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tempus AI, Inc. Class A (TEM) and Rocket Pharmaceuti...

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Rocket Pharmaceuticals (RCKT)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on BrightSpring Health Services, Inc. (BTSG), Monte Ros...

Wall Street Analysts Are Bullish on Top Healthcare Picks

An announcement from Tongcheng Travel Holdings Limited ( ($HK:0780) ) is now available. Tongcheng Travel Holdings Limited has scheduled a board mee...

Tongcheng Travel Sets Date to Approve and Publish Interim Results

Tempus AI, Inc. Class A (TEM) has disclosed a new risk, in the Corporate Activity and Growth category. The proposed acquisition of Personalis will ...

Tempus AI–Personalis Deal: Integration Risks, Rising Costs, and Regulatory Scrutiny Could Undermine Synergy Gains

Bank of China analyst maintained a Buy rating on Tongcheng Travel Holdings Limited on July 29 and set a price target of HK$19.50. The company’s sha...

Bank of China Sticks to Its Buy Rating for Tongcheng Travel Holdings Limited (0780)

Tongcheng Travel Holdings Limited ( ($HK:0780) ) has provided an announcement. Tongcheng Travel Holdings, Dida Inc. and eLong, Inc. jointly announc...

Tongcheng Travel and eLong Launch Cash Offer for All Shares in Dida Inc.

An update from Tempest Minerals Limited ( ($AU:TEM) ) is now available. Tempest Minerals has reported an inferred mineral resource estimate for its...

Tempest Minerals Advances Remorse Iron Deposit via GreenSteel Partnership

In a report released yesterday, Toby Ogg from J.P. Morgan maintained a Buy rating on Temenos, with a price target of CHF90.00. The company’s shares...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	TEM	$66.17	-8.97%	11.88M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	TEM	$66.17	-9.0%	11.88M
3
4
5
6

TEM

Get Tempus AI, Inc. Data in Excel

Get Tempus AI, Inc. Data in Excel